483 SCA Pharmaceuticals Mar 2018

483 SCA Pharmaceuticals Mar 2018

Jonathan Matrisciano FDA, Dien Nguyen FDA$119.00 - Available Now

FDA investigators audited the SCA Pharmaceuticals - Windsor, CT, United States facility and issued inspectional observations (via FDA 483) on 05 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Mar 2018
  • Location: Windsor, United States
  • FEI: 3013736415
Add To Cart